GBM cells around necrotic regions have been shown to express elevated levels of TGF-β along with stem cell markers such as CD133, suggesting that tissue hypoxia may promote TGF-β signaling which induces an epithelial-mesenchymal transition resulting in the stem cell phenotype [105]. The gene discussed is PROM1; the disease is glioblastoma.